Tomohide Tsukahara Selected Research

Tomohide Tsukahara Research Topics

Disease

72	Neoplasms (Cancer) 05/2024 - 08/2004
18	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 08/2005
16	Osteosarcoma (Osteogenic Sarcoma) 10/2023 - 01/2003
9	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 06/2011
9	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2013
7	Colonic Neoplasms (Colon Cancer) 09/2023 - 06/2011
7	Carcinoma (Carcinomatosis) 07/2023 - 10/2016
6	Testicular Neoplasms (Testicular Cancer) 01/2023 - 01/2016
6	Synovial Sarcoma (Synovioma) 09/2012 - 08/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 10/2020
4	Lung Neoplasms (Lung Cancer) 01/2017 - 02/2005
3	Squamous Cell Carcinoma of Head and Neck 09/2023 - 05/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 01/2017
3	Melanoma (Melanoma, Malignant) 04/2023 - 02/2005
3	Carcinogenesis 01/2021 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2019 - 01/2013
2	Breast Neoplasms (Breast Cancer) 11/2023 - 04/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023 - 04/2022
2	Granuloma 06/2023 - 03/2021
2	COVID-19 04/2023 - 01/2023
2	Microsatellite Instability 01/2022 - 01/2017
2	Tuberculosis (Tuberculoses) 03/2021 - 01/2021
2	Adenocarcinoma of Lung 11/2020 - 01/2013
2	Adenocarcinoma 08/2019 - 01/2017
2	Hypoxia (Hypoxemia) 12/2016 - 05/2015
1	Stomach Neoplasms (Stomach Cancer) 05/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024
1	Esophageal Squamous Cell Carcinoma 11/2023
1	Mouth Neoplasms (Oral Cancer) 09/2023
1	Ischemia 04/2023
1	Skin Neoplasms (Skin Cancer) 04/2023
1	Diarrhea 04/2023
1	Infections 04/2023
1	Cholangitis 04/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2023
1	Communicable Diseases (Infectious Diseases) 01/2023

Drug/Important Bio-Agent (IBA)

36	AntigensIBA 10/2023 - 01/2003
35	Peptides (Polypeptides)IBA 05/2024 - 08/2002
15	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2016
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2007
9	HLA Antigens (Human Leukocyte Antigens)IBA 05/2024 - 02/2008
8	HLA-A24 AntigenIBA 10/2020 - 08/2002
6	SurvivinIBA 02/2020 - 06/2011
6	Protein Subunit VaccinesIBA 08/2019 - 02/2005
6	HLA-A Antigens (HLA-A)IBA 08/2014 - 12/2002
5	Messenger RNA (mRNA)IBA 01/2020 - 01/2009
5	EpitopesIBA 04/2019 - 06/2009
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023 - 01/2016
4	Oxidoreductases (Dehydrogenase)IBA 04/2017 - 05/2015
3	Aldehyde DehydrogenaseIBA 05/2024 - 01/2016
3	Complementary DNA (cDNA)IBA 10/2023 - 08/2004
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2023 - 02/2007
3	Formaldehyde (Formol)FDA Link 02/2023 - 12/2006
3	ParaffinIBA 02/2023 - 12/2006
3	Aldehyde Dehydrogenase 1 FamilyIBA 01/2022 - 04/2017
3	incomplete Freund's adjuvantIBA 02/2020 - 06/2011
3	HLA-B55 antigenIBA 04/2019 - 06/2009
3	Histocompatibility Antigens Class IIBA 01/2017 - 05/2015
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 08/2014 - 02/2008
3	Cancer VaccinesIBA 01/2013 - 04/2009
2	Calcibiotic Root Canal SealerIBA 04/2024 - 01/2017
2	Odorant Receptors (Odorant Receptor)IBA 09/2023 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 07/2023 - 01/2023
2	Small Interfering RNA (siRNA)IBA 04/2023 - 04/2016
2	Differentiation AntigensIBA 04/2023 - 01/2023
2	Transcription Factors (Transcription Factor)IBA 04/2023 - 08/2016
2	Immune Checkpoint ProteinsIBA 04/2023 - 04/2017
2	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2019
2	LigandsIBA 11/2021 - 08/2019
2	NivolumabIBA 07/2021 - 06/2021
2	pembrolizumabIBA 07/2021 - 11/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021 - 01/2019
2	Photosensitizing Agents (Photosensitizers)IBA 02/2021 - 01/2019
2	B7-H1 AntigenIBA 11/2020 - 04/2017
2	Single-Chain AntibodiesIBA 10/2020 - 08/2014
2	Gemcitabine FDA Link 08/2019 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 08/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2018 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	Monoclonal AntibodiesIBA 08/2014 - 12/2006
2	VaccinesIBA 09/2011 - 04/2009
1	AldehydesIBA 05/2024
1	NLR ProteinsIBA 11/2023
1	eribulin FDA Link 11/2023
1	GTP-Binding Proteins (G-Protein)IBA 09/2023
1	Interferon-gamma (Interferon, gamma)IBA 06/2023
1	CEACAM1 ProteinIBA 04/2023
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 02/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023
1	AntibodiesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	MART-1 AntigenIBA 01/2023
1	HLA-A*24:02 antigenIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023

Therapy/Procedure

44	Immunotherapy 05/2024 - 01/2003
27	Therapeutics 10/2023 - 02/2007
14	Drug Therapy (Chemotherapy) 05/2024 - 08/2004
7	Radiotherapy 05/2024 - 01/2013
2	Aftercare (After-Treatment) 03/2021 - 01/2013
1	Extracorporeal Membrane Oxygenation 04/2023